CBTs provided a small incremental benefit over control interventions in reducing pain , negative mood and disability at the end of treatment and at long-term follow-up .
The dropout rates due to any reason did not differ between CBTs and controls
BACKGROUND Fibromyalgia ( FM ) is a clinical ly well-defined chronic condition of unknown aetiology characterized by chronic widespread pain that often co-exists with sleep disturbances , cognitive dysfunction and fatigue .
Patients often report high disability levels and negative mood .
Psychotherapies focus on reducing key symptoms , improving daily functioning , mood and sense of personal control over pain .
OBJECTIVES To assess the benefits and harms of cognitive behavioural therapies ( CBTs ) for treating FM at end of treatment and at long-term ( at least six months ) follow-up .
Differential efficacy of a cognitive – behavioral intervention versus pharmacological treatment in the management of fibromyalgic syndrome
Abstract Given that studies about the differential efficacy of existing treatments in fibromyalgia syndrome are scarce , the aim of this study was to compare the differential efficacy of a cognitive – behavioral and a pharmacological therapy on fibromyalgia . Using a r and omized controlled clinical trial , 28 fibromyalgic patients were assigned to one of following experimental conditions : ( a ) pharmacological treatment ( i.e. , cyclobenzaprine ) , ( b ) cognitive – behavioral intervention ( i.e. , stress inoculation training ) , ( c ) combined pharmacological and cognitive – behavioral treatment and ( d ) no treatment . The results show the superiority of  cognitive – behavioral intervention to reduce the severity of fibromyalgia both at the end of the treatment and at follow-up . We conclude that cognitive – behavioral interventions must be considered a primary treatment of fibromyalgia syndrome
CBTs provided a small incremental benefit over control interventions in reducing pain , negative mood and disability at the end of treatment and at long-term follow-up .
The dropout rates due to any reason did not differ between CBTs and controls
BACKGROUND Fibromyalgia ( FM ) is a clinical ly well-defined chronic condition of unknown aetiology characterized by chronic widespread pain that often co-exists with sleep disturbances , cognitive dysfunction and fatigue .
Patients often report high disability levels and negative mood .
Psychotherapies focus on reducing key symptoms , improving daily functioning , mood and sense of personal control over pain .
OBJECTIVES To assess the benefits and harms of cognitive behavioural therapies ( CBTs ) for treating FM at end of treatment and at long-term ( at least six months ) follow-up .